F16.220
Hallucinogen dependence with intoxication, uncomplicated
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F16.220 refers to a condition characterized by dependence on hallucinogenic substances accompanied by intoxication, but without any complications. This condition involves a persistent craving or reliance on hallucinogens, coupled with episodes of intoxication that affect mental and physical functioning. While it signifies a dependence, it does not involve additional health issues or complications that could make treatment more complex. Recognizing and understanding this condition can help individuals seek appropriate support to manage their dependence effectively.
Causes & Symptoms
Clinical Causes: Frequent use of hallucinogenic substances such as LSD, psilocybin (magic mushrooms), peyote, or mescaline. Psychological factors including stress, mental health conditions, or peer pressure that increase substance use. Environmental factors such as availability of hallucinogens and social circles encouraging use. Genetic predispositions that might influence susceptibility to substance dependence.
Key Symptoms: Strong desire or craving to use hallucinogenic substances. Repeated unsuccessful efforts to cut down or stop use. Tolerance, requiring increased amounts of the substance to achieve the same effect. Experiencing withdrawal symptoms when not using, such as irritability, anxiety, or physical discomfort. Preoccupation with obtaining and using hallucinogens. Neglect of responsibilities and social activities due to substance use. Persistent use despite awareness of the harmful consequences.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive medical and psychological assessment. Healthcare providers evaluate the individual's substance use history, including patterns and frequency, as well as any physical or mental health issues. Diagnostic criteria from recognized guidelines, such as the DSM-5, are used to confirm substance dependence, specifically related to hallucinogens. Laboratory tests or urine screenings may also support diagnosis by detecting recent substance use. A key aspect is establishing that the dependence is ongoing and impacts daily functioning, while noting the absence of significant medical or psychiatric complications at this stage.
Treatment Protocols: Treatment strategies for hallucinogen dependence with uncomplicated intoxication focus on behavioral therapies and support systems. Approaches include:
Clinical Advice & FAQs
Billing Guidance
Is F16.220 a billable ICD-10 code?
Yes, F16.220 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F16.220?
Clinical documentation must specify the nature of Hallucinogen dependence with intoxication, uncomplicated and any associated comorbidities for accurate reporting.
Cite this Clinical Reference